Health
MS lifeline as drug that can slow disease listed – Chinchilla News
Patients who develop the second progressive stage of Multiple Sclerosis will only have to pay $41 for a drug that helps slow down the disease.
Patients living with multiple sclerosis have been granted a lifeline with the federal government listing a drug that can help slow down the progression of the disease.
The move will mean all patients who might benefit from “Mayzent” will only have to pay $41 per script rather than the estimated $25,000 yearly cost.
Multiple sclerosis, known as MS, is the most commonly acquired neurological disease in younger adults with more than 25,600 Australians living with the condition.
The average age of diagnosis…
-
General7 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
General23 hours agoParis opens River Seine for public swimming for first time since 1923
-
General21 hours agoWest Indies vs Australia live: Second Test, day three from Grenada
-
General21 hours agoDr Daniel Hunt, Michael Long and Christine Anu celebrated at 50th NAIDOC Week Awards